... Proudly operating under the Union Jack in China these days are firms such as BP, Shell, Climate Change Capital, GSK, AstraZeneca, Dyson, Rolls Royce, British Sugar, Vodafone, Arup, Foster & Partners and a large number of banking, insurance and professional...

...The doctors said the clinic stopped using Diprivan to treat such patients because of the danger. The drug's manufacturer, AstraZeneca P.L.C., warns that patients using Diprivan should be continuously monitored, and in a tiny number of cases patients using...

...hours of fasting, and postprandial glucose, a measure of a person's blood glucose after a meal. Bristol-Myers Squibb and AstraZeneca Collaboration Bristol-Myers Squibb and AstraZeneca entered into a collaboration in January 2007 to enable the companies to...

...The doctors said the clinic stopped using Diprivan to treat such patients because of the danger. The drug's manufacturer, AstraZeneca P.L.C., warns that patients using Diprivan should be continuously monitored, and in a tiny number of cases patients using...

...The doctors said the clinic stopped using Diprivan to treat such patients because of the danger. The drug's manufacturer, AstraZeneca PLC, warns that patients using Diprivan should be continuously monitored, and in a tiny number of cases patients using it...

...by its generic name Propofol, is administered intravenously in operating rooms as a general anesthetic, the manufacturer AstraZeneca said Friday. Tuesday, join CNN for all day coverage as the world celebrates the life of a worldwide pop icon, and don't miss...

...utility, struggled against rumours that it would launch a rights issue and registered a modest gain in the second quarter. AstraZeneca, meanwhile, found the going easier. Its shares rose 14 per cent between April and July, cutting the year-to-date loss to...

...early adulthood, and can include delusions, hallucinations, paranoia, and depression. Although some antipsychotic drugs, such as AstraZeneca's Seroquel and Eli Lilly's Zyprexa, can alleviate symptoms, there is no known cure for the disease, and the drugs can...

...EGFR-targeted anticancer Iressa (gefitinib) has received approval in the EU from the European Commission for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations in the EGFR (epidermal growth...

...pill Iressa has been approved for certain lung cancer patients in Europe, reviving the fortunes of a product that had until recently been largely written off by industry analysts. The drugmaker said the European Commission had granted marketing authorisation...